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10th IEIDC Abstracts / Journal of Equine Veterinary Science 39 (2016) S20eS22S22base pairs) and structural polyprotein (C-E3-E2-6K-E1, 3762 base
pairs) were identical between MI-110 and 14-I-605. The nucleo-
tide and amino acid sequences of these genes were highly
conserved between MI-110 and 14-I-605 (nsP1234, 98.5% for
nucleotides and 99.5% for amino acids; C-E3-E2-6K-E1, 98.7% for
nucleotides and 99.8% to 99.9% for amino acids). Antisera against
MI-110 and 14-I-605 had almost equal titers against both the
homologous virus and the heterologous virus. These results
showed that there was little difference between MI-110 and 14-I-
605 genetically and antigenically. Therefore, the current vaccine
containing MI-110 should be effective against 14-I-605, and it is
unlikely that virus mutation was a direct cause of the 2014
outbreak.
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Institut Pasteur, 75 Paris, FranceHepatitis C virus (HCV) is one of the main causes of end stage
liver diseases (cirrhosis and hepatocellular carcinoma) in
humans. In vivo studies have been hampered by a lack of access
to relevant animal models. Until recently, the genus Hepacivirus
was comprised of seven HCV genotypes, plus GBV-B that infects
New World monkeys. Within the past few years, new hep-
aciviruses were identiﬁed in dogs and horses (also called
canine/equine or non-primate hepaciviruses), in Old World
monkeys (Colobus guereza), as well as in rodents (Myodes
glareolus and Rhabdomys pumilio) and bats. Yet, the data
available regarding newly identiﬁed hepacivirus infections is
still limited, including in horses. So far, few studies have re-
ported PCR positive horses in different countries (USA, Scot-
land, Germany, Japan, Brazil and Hungary). The aim of our study
was to determine the prevalence of active hepacivirus in-
fections in horses. A RT-qPCR adapted from the test described
by Burbello et al. was developed according to the AFNOR norm
U47-600-2. We detected 69 positive horses out of 1229
screened with this assay (5,6%). Positive horse samples origi-
nated from all parts of France. The number of viral genomes
circulating in the blood of hepacivirus-infected horses ranged
from 1.15 x 104 to 2.8 x 109 copies/mL, with two third of the
results above a threshold of 4.26 x 107 copies/mL. There was no
evidence of concomitant hepatic inﬂammation in the sera, as
tested by the levels of gamma-glutamyl transferase and gluta-
mate deshydrogenase. A one-year follow-up study in 7 horses
from the same stud farm showed that, from the time of
detection, infection persisted up to 18 months. A phylogenetic
analysis was performed based on the nucleotide sequences of
the 5’-untranslated region of the genome, as well as of the
genes encoding the nonstructural proteins 3 and 5B. The result
of this analysis suggests that all positive horses identiﬁed in
France are infected with equine hepacivirus variants distinct
from those previously reported. The present study demon-
strates for the ﬁrst time the presence of a signiﬁcant proportion
of ongoing equine hepacivirus infections in the horse herds in
France. Determining the consequences of persistent hepacivirus
infections in horses warrants further investigation.
